Your Location:
Home >
Browse articles >
Mechanism of Yizhi Qingxin Prescription in Regulating PKA/CaN Pathway to Improve Cognitive Function in Alzheimer's Disease Model Mice
Mechanism of Yizhi Qingxin Prescription in Regulating PKA/CaN Pathway to Improve Cognitive Function in Alzheimer's Disease Model Mice
Enhanced Publication- Chinese Journal of Experimental Traditional Medical Formulae Vol. 32, Issue 3, Pages: 97-108(2026)
DOI: 10.13422/j.cnki.syfjx.20252009
Revised:2025-09-10 ,
Accepted:18 September 2025
Scan QR Code
AI Introduction
Full Text(HTML)
Figs( 5 ) Tabs( 7 )
References
Publication Info
Metrics
137
Views
175
Downloads
0
CSCD
Alert me when the article has been cited
Submit
Tools
- BibTeXDownload
- EndnoteDownload
- RefMan Download
- NoteExpressDownload
- NoteFirstDownload
Related Articles
Regulatory Pathways of Mitochondrial Dynamics Imbalance in Alzheime's Disease and Traditional Chinese Medicine Intervention: A Review
Danggui Shaoyaosan Alleviates Cognitive Impairment by Regulating Ketone Body Metabolism and Glutamate/AMPAR Pathway
Mechanisms of Shangxia Liangji Danin Improving Cognitive Function in AD Mice Based on PI3K/Akt Signaling Pathway
Mechanisms of Action of Angelica sinensis in Prevention and Treatment of Alzheimer's Disease: A Review
Regulatory Effect and Mechanisms of Liuhuang Zhike Prescription on Glycemic Control in db/db Mice via AMPK/Akt/GSK-3β Signaling Pathway
Related Author
LYU Peiyao
MENG Binru
LIU Chuanfeng
LI Jiaxin
LI Bin
WANG Shasha
WANG Xin
GONG Kexin
Related Institution
Affiliated Hospital of Chengdu University of Traditional Chinese Medicine
Science and Technology Innovation Center, Guangzhou University of Chinese Medicine
Zhongshan Hospital of Traditional Chinese Medicine Affiliated to Guangzhou University of Chinese Medicine
Hubei University of Chinese Medicine
Huanggang Hospital of Traditional Chinese Medicine Affiliated to Hubei University of Chinese Medicine


